Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events

Liraglutide is a GLP-1 analog (glucagon like peptide-1) used primarily in the treatment of diabetes mellitus type 2 (DM2) and obesity. The literature starts to suggest that liraglutide may reduce the effects of ischemic stroke by activating anti-apoptotic pathways, as well as limiting the harmful ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Wiciński, Michał, Socha, Maciej, Malinowski, Bartosz, Wódkiewicz, Eryk, Walczak, Maciej, Górski, Karol, Słupski, Maciej, Pawlak-Osińska, Katarzyna
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429395/
https://ncbi.nlm.nih.gov/pubmed/30823403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20051050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados